Frank Svoboda Sells Shares of Globe Life Inc.
Globe Life's CEO, Frank Svoboda, sold company shares on June 11, 2026.
Key Points
- Frank Svoboda, Co-Chairman & CEO of Globe Life Inc., sold 10,000 shares on June 11, 2026, at a price of $166.76 each.
- Globe Life Inc. trades on the NYSE under the ticker GL, with a market cap of $12.95 billion and a P/E ratio of 11.53.
- Analysts maintain a buy rating on Globe Life, with Piper Sandler setting a price target of $175 as of May 26, 2026.
Frank Svoboda, Co-Chairman and CEO of Globe Life Inc. (NYSE: GL), sold 10,000 shares of the company's stock on June 11, 2026. The shares were sold at an average price of $166.76 each. This transaction was not part of a pre-arranged trading plan.
Insider Buying and Selling at Globe Life Inc.
On June 11, 2026, Frank Svoboda sold 10,000 shares at $166.76 each. Earlier that day, he also bought 10,000 shares at $100.74. On June 12, 2026, he sold another 10,000 shares at $166.68 and bought 10,000 shares at $100.74.
Other Institutional Activity in Globe Life
BlackRock, Inc. trimmed its position in Globe Life by 146,546 shares, ending with 5,542,531 shares valued at about $771.35 million. Vanguard Capital Management LLC added 5,149,992 shares, totaling 5,149,992 shares worth approximately $716.72 million. Invesco Ltd. increased its stake by 67,674 shares, holding 4,016,350 shares valued at $558.95 million. State Street Corp grew its holdings by 485,155 shares, reaching 3,658,664 shares valued at $509.18 million.
Globe Life Inc. Stock Snapshot
Globe Life Inc. (NYSE: GL) traded near $166.76. The company has a market capitalization of approximately $12.95 billion and a P/E ratio of 11.53. Its stock has ranged between $116.73 and $168.27 over the past year. The 50-day moving average is $152.97, while the 200-day moving average is $142.41.
Recent Earnings
Globe Life reported revenue of $6.07 billion, with a growth rate of 5.4%. The company's earnings per share (EPS) stood at $14.46, with a net margin of 19.38% and a return on equity (ROE) of 20.46%. The next earnings report is expected on July 22, 2026.
Dividend
Globe Life offers an annual dividend rate of $1.32, translating to a yield of 0.79% and a payout ratio of 7.89%. The company's ex-dividend date was not specified.
Analysts Set New Price Targets
On May 26, 2026, Piper Sandler maintained its buy rating on Globe Life with a price target of $175. Morgan Stanley also maintained its buy rating with a target of $181 as of May 21, 2026. Overall, analysts have a consensus buy rating, with a mean price target of $175.91 from 11 opinions.
About Globe Life Inc.
Globe Life Inc., based in McKinney, Texas, provides life and supplemental health insurance products to lower middle- and middle-income families in the United States. The company operates through three segments: Life Insurance, Supplemental Health Insurance, and Investments. Founded in 1900, Globe Life offers a variety of insurance products, including whole and term life insurance, Medicare supplements, and more, through direct channels and independent agents.
Bottom Line
Frank Svoboda's recent transactions in Globe Life Inc. shares are noteworthy for investors tracking insider activity. Globe Life, a significant player in the life insurance sector, continues to show strong financial performance with solid revenue growth and profitability. While insider transactions can provide insights, it's important to remember that they are not direct buy or sell signals.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.